Augmentation-Mastopexy — Breast Lift With Implants

A pure breast lift reshapes what you already have. An augmentation-mastopexy reshapes and restores — lifting the breast and adding volume in the same operation. For the right patient, it is one of the most transformative procedures in plastic surgery. For the wrong patient, it is over-engineered. This guide explains who it's for, how the implant is chosen, and the honest trade-offs of combining two operations into one.

When is augmentation-mastopexy indicated?

The typical patient has experienced:

• Pregnancy and breastfeeding — the classic post-lactation deflation, where the upper pole empties and the skin envelope loosens
• Significant weight loss — after bariatric surgery or major lifestyle change, leaving deflated, sagging breasts
• Age-related volume loss — gradual involution of glandular tissue, typically after the late 40s
• Congenital hypoplasia with ptosis — smaller breasts that have also descended over time

What these share is the combination of sagging and volume loss. A lift alone restores position but leaves the breast empty on top. An augmentation alone adds volume but without lifting a low nipple will look unnatural. Doing both addresses both problems.

When is augmentation-mastopexy not the answer?

• Adequate volume with sagging only. A pure autologous lift is simpler, safer and has lower long-term maintenance.
• Low volume without sagging. Standard augmentation is enough; no lift needed.
• Very thin tissue covering over a large implant. Long-term implant-related changes (rippling, visible edges, stretching) are a concern in very thin patients asking for large implants.
• Active smoker. Nicotine compromises blood supply to both the skin flaps and the nipple pedicle; a combined operation amplifies this risk.

One operation vs staged (two operations)

A long-running debate in plastic surgery: do the lift and augmentation together, or in two stages?

Round vs anatomical implant in augmentation-mastopexy

Implant placement in a lifted breast

The implant can go above the muscle (subfascial), under the muscle (submuscular), or in a dual-plane configuration. In augmentation-mastopexy, subfascial or dual-plane placement is most common — both give enough soft-tissue coverage while minimising the "animation deformity" that can occur with fully submuscular implants in a lifted breast.

Scar pattern in augmentation-mastopexy

The scar pattern follows ptosis grade, exactly as in a pure lift:

• Grade 1 (mild): periareolar scar (sometimes combined with an implant through an inframammary incision)
• Grade 2 (moderate): vertical (lollipop) scar
• Grade 3 (severe): Wise (anchor) scar

Adding an implant does not add to the scar length — the implant is placed through the existing lift incision.

Recovery — the same as a lift

Recovery after augmentation-mastopexy is very similar to a pure autologous lift:

• Most patients return to light activity by day 7–10
• Desk work at 2 weeks
• Full exercise at 6 weeks
• Final shape at 6–12 months
• Scar maturation over 12–24 months

The surgical bra is worn for 6 weeks. Some surgeons add a breast band to help the implant settle into its final position in the first weeks.

Long-term maintenance

Augmentation-mastopexy has a higher long-term revision rate than either lift alone or augmentation alone — around 10–15% at 10 years, primarily for implant-related issues (capsular contracture, implant ageing, rippling) or for additional lift to counter ongoing tissue relaxation. This is a real consideration, though most patients still describe the operation as the right choice for their situation.

Risks specific to augmentation-mastopexy

• Nipple-areola blood supply compromise — very rare in experienced hands; the risk is higher when the nipple must be moved a long distance alongside implant placement
• Wound healing difficulty — the dual forces on the skin (implant pushing outward, skin closure pulling inward) can slow healing at the T-junction of a Wise pattern
• Implant-related complications — capsular contracture, malposition, rupture (all standard augmentation risks)
• Need for future revision — slightly higher than for either operation alone

These are all discussed openly at consultation.

Implant size selection

One of the most important decisions in augmentation-mastopexy, often given less attention than it deserves. The interaction between mastopexy and implant size affects both aesthetic outcome and long-term shape stability.

Constraints

• Tissue limitations — the mastopexy reshapes existing tissue around the implant; very large implants strain the lift and can cause bottoming out
• Skin envelope — must accommodate the implant comfortably; over-tight closure causes wound healing issues
• Chest wall dimensions — implant base width must fit the patient's chest; oversized implants extend laterally beyond the breast meridian
• Patient body habitus — proportionate implant size respects the rest of the body shape

Selection methods

• Sizers in surgical bra — disposable implant-volume sizers worn in a surgical bra during pre-op consultation; gives realistic feel and visual approximation
• 3D imaging — Vectra/Crisalix systems simulate different volumes; useful as communication tool but not exact
• Tissue-based measurements — chest wall measurements determine appropriate implant base width
• Photographic analysis — surgeon's visual assessment of patient body proportions

Typical ranges in 2026

Note: implant volume in augmentation-mastopexy is typically 50-75cc smaller than pure augmentation for the same body frame, because the mastopexy contributes shape that pure augmentation alone can't.

BIA-ALCL — what to know

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare cancer associated specifically with certain textured implants. Awareness has shifted implant choice significantly:

Risk profile

• Macrotextured implants (Allergan Biocell specifically) had highest reported rates; withdrawn from many markets
• Microtextured implants have lower reported rates but not zero
• Smooth implants have no documented BIA-ALCL cases to date
• Reported global cases: approximately 1,200 (vs millions of implants placed) — rare but real

Symptoms and surveillance

• Late-onset breast swelling (typically 7-10 years post-implantation, can be earlier or later)
• New asymmetry developing years after surgery
• Lump or mass formation in the breast or armpit
• Persistent pain or skin changes
• Surveillance: ultrasound for any new symptoms; aspiration of fluid for cytology if seroma identified; CD30 immunohistochemistry confirms diagnosis

Why this matters for augmentation-mastopexy

Smooth round implants are the current default for most augmentation-mastopexy cases due to BIA-ALCL associations with certain textured implants. Smooth implants offer: lower BIA-ALCL risk, no rotation concerns (round shape is symmetric), softer feel. Textured anatomical implants used in fewer cases — specific anatomical indication for shape control outweighing the texture risk.

Imaging considerations after surgery

Implants affect breast imaging — important for patients of mammography age (40+ in most countries, earlier with family history):

Mammography

• Implants visible on mammogram; specific positioning views (Eklund displacement) reveal more breast tissue
• Mammography is still the screening mammogram standard for women with implants
• Inform mammographer of implants — affects technique and interpretation
• Submuscular and dual-plane placement allow more breast tissue visualization than subglandular

Ultrasound

• Useful for assessing implant integrity, capsule status, and any adjacent breast tissue findings
• Not affected by implants like mammography is
• Used for breast surveillance + targeted assessment of any specific concern

MRI

• Most sensitive for both breast tissue and implant assessment
• FDA recommendation: silicone implant MRI surveillance at 5-6 years post-implantation, then every 2-3 years
• Different protocol in UK and EU; discuss with surgeon and GP
• Not routinely needed for asymptomatic patients with intact implants in most international guidelines

When to stage rather than combine

While single-stage augmentation-mastopexy is appropriate for the majority of cases in expert hands, two-stage approach (mastopexy first, augmentation 6-12 months later) suits specific scenarios:

Two-stage indicated when:

• Severe Grade III ptosis with extensive reshaping needed — mastopexy alone may produce sufficient improvement
• Marginal blood supply concerns in patient (smoker, prior radiation, very thin tissue) — single-stage adds vascular risk
• Patient unsure about implant ownership — mastopexy first allows evaluation of result before committing to implants
• Patient wants ability to optimize each procedure independently
• Body weight not yet stable — significant remaining weight loss expected
• Recent pregnancy with continued breast volume changes

Two-stage cost

Two-stage approach costs approximately 80% more than single-stage combined surgery (two operative fees, two anaesthesia fees, two recoveries). For most patients, single-stage represents better value when surgically appropriate.

Long-term maintenance

Implant ownership is a long-term commitment that augmentation-mastopexy patients should fully understand:

Implant lifespan

• Modern silicone implants typically last 10-20 years
• Some patients keep implants 25+ years without issue
• Others need earlier replacement due to capsular contracture, rupture, or aesthetic concerns
• Eventual replacement should be expected and budgeted for

Capsular contracture

• 5-15% rate over 10 years (Baker grade III-IV requiring revision)
• Symptoms: firmness, distortion, pain in the breast
• Treatment: capsulectomy + implant exchange; may need pocket change
• Recurrence rate after revision: 10-20%

Revision rate

Augmentation-mastopexy has higher long-term revision rate (15-25% over 10 years) than pure mastopexy (5-10%) or pure augmentation (10-15%). Reasons for revision: implant exchange (lifestyle, size change preference), capsular contracture, recurrent ptosis, scar revision. The 10-year revision discussion should happen pre-operatively, not at the time of revision.

Patient expectations

Specific honest conversations to have with surgeon during pre-operative consultation:

• "What implant size will best suit my body, and why?"
• "What internal support will you use, given the lift + implant combination?"
• "What's your revision rate for augmentation-mastopexy at 5 and 10 years?"
• "What's your protocol if I develop capsular contracture?"
• "How will you handle BIA-ALCL surveillance and any symptoms?"
• "What if I want my implants removed in the future — explant only, or explant + lift?"

A surgeon comfortable with these long-term questions is one likely thinking about your long-term outcomes, not just the immediate post-op result.

Frequently asked questions